Omada Health's DSMES+CGM lowers HbA1c in type 2 diabetes
The randomized controlled trial showed significant improvements in glucose management indicators at 6 months.
See the latest news and media coverage for Omada. We track all announcements, press releases, and industry mentions in real time, all in one place.
Virtual chronic disease management programs
omadahealth.comLast updated
In short: Omada achieved a significant financial turnaround in Q1 2026, reporting a 42% revenue surge and an expanded member base of over one million users.
The randomized controlled trial showed significant improvements in glucose management indicators at 6 months.
Revenue rises 42% to $78 million; members surpass 1 million. Gross margin improves to 62%; announces PBM partnerships and GLP-1 study.
It expands GLP-1 care access for employers, offering clinical evaluation, prescribing, and lifestyle support amid rising patient costs and care gaps.
It enables employers to offer anti-obesity medication support via cash-pay channels, including lifestyle counseling and clinical oversight. Research shows longer medication adherence and sustained weight loss.
Telehealth companies offer lifestyle support so people taking obesity drugs can have the most success losing weight. But employers also want the telehealth providers to...
Detailed price information for Omada Health Inc (OMDA-Q) from The Globe and Mail including charting and trades.
Detailed price information for Omada Health Inc (OMDA-Q) from The Globe and Mail including charting and trades.
For investors it matters because ... of interest or hidden concentration of power, and affects transparency and risk in the stock. ... See more from...
Track Omada and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Omada and other trending companies.